Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
Radiat Oncol. 2023 May 5;18(1):75.
doi: 10.1186/s13014-023-02245-0.
1 School of Medicine, Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Chengdu, Sichuan, 610041, China.
2 Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan, 610041, China.
3 Department of Thoracic Surgery, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
4 Department of Thoracic Surgery, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China. [email protected].
5 Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan, 610041, China. [email protected].